Naltrexone/bupropion for obesity: an investigational combination pharmacotherapy for weight loss
Quick answer: In the Phase 2 clinical trial (Jastreboff et al., 2023, New England Journal of Medicine ), retatrutide was given by once-weekly subcutaneous injection across a 112mg range
u003cstrongu003eWhat side effects can Gentle Patches cause?u003c/strongu003e u003ca href=u0022#Real-User-Experienceu0022u003eGentle Patches may cause side effectsu003c/au003e mostly related to skin, such as redness, itchiness, or mild irritation from the adhesive
Tolerability issues leading to dose reductions may limit the therapeutic benefit achievable in some patients
Each pill contains 3mg Retatrutide in oral tablet form
As part of the evolving R&D pipeline, Figure 3 summarises the emerging research frontiers into the potential therapeutic applications of GLP-1s beyond cardiometabolic conditions, including neurodegeneration, addiction, mental health, cancer, womens health and asthma